Trijardy XR 2.5 mg/1 (Empagliflozin, Linagliptin, Metformin Hydrochloride TABLET, EXTENDED RELEASE) 2.5 mg/1

Trijardy XR 2.5 mg/1 combines empagliflozin, linagliptin, and metformin hydrochloride for blood sugar management. This extended-release tablet supports glucose control in adults with type 2 diabetes.

Strength

2.5 mg/1

Pack Size

180 TABLET, EXTENDED RELEASE in 1 BOTTLE (0597-0395-23)

Manufacturer / TM Owner

Boehringer Ingelheim Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Trijardy XR 2.5 mg/1 is designed to help manage blood sugar levels in adults with type 2 diabetes. It combines three active ingredients to support glucose control. This medication is typically used as part of a broader treatment plan that includes diet and exercise. People often ask, 'What is Trijardy XR used for?' and the answer is that it aids in maintaining stable blood sugar levels.

Side Effects

Common effects of Trijardy XR 2.5 mg/1 may include gastrointestinal discomfort, such as nausea or diarrhea, especially when first starting the medication. Some users may also experience urinary tract infections or low blood sugar. These effects can vary and are not experienced by everyone.

Precautions & Warnings

Trijardy XR 2.5 mg/1 should be handled with care. It is important to follow the advice of a healthcare provider regarding its use. This medication is not suitable for everyone, particularly those with certain kidney conditions or a history of pancreatitis. Always inform your healthcare provider about any other medications you are taking.

Avoid Interactions

Trijardy XR 2.5 mg/1 may interact with other medications, including certain antibiotics, antifungal agents, and drugs that affect kidney function. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods may also affect how this medication works.

Frequently Asked Questions

Trijardy XR 2.5 mg/1 is used to help manage blood sugar levels in adults with type 2 diabetes.

Trijardy XR 2.5 mg/1 is an extended-release tablet taken orally, typically once daily. Follow the instructions provided by your healthcare provider.

Common side effects may include gastrointestinal discomfort, urinary tract infections, and low blood sugar.

Trijardy XR 2.5 mg/1 may interact with other medications, so it is important to discuss all current medications with a healthcare provider.

Trijardy XR 2.5 mg/1 is not suitable for everyone, particularly those with certain kidney conditions or a history of pancreatitis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.